Cervical cancer awareness campaign targets GPs and nurses
June 26, 2009Medical Communications, Sales and Marketing NHS, vaccines
GPs and practice nurses are to be targeted in a government awareness campaign to ensure cervical cancer is spotted earlier …
Novartis gains approval for first Japanese biosimilar
June 25, 2009Research and Development, Sales and Marketing Novartis, generics
Japan has approved its first biosimilar medicine – the recombinant human growth hormone somatropin from Novartis' generic arm Sandoz. The …
Merck takes aim at neglected tropical diseases
June 25, 2009Research and Development, Sales and Marketing Africa, Merck, Orphan
Merck & Co is participating in two projects designed to help improve healthcare in Africa. The pharma giant will join …
GSK signs arthritis drug development collaboration
June 25, 2009Research and Development, Sales and Marketing Deals, GSK
GlaxoSmithKline and Oxford-based Chroma Therapeutics are linking up to identify small molecule therapeutics in a bid to combat conditions like …
Dendreon sets aside $50m for Provenge facility
June 24, 2009Manufacturing and Production Dendreon, US
US biotechnology company Dendreon revealed its confidence in lead drug Provenge for prostate cancer with the announcement it will invest …
Pharma agrees cost-saving deal with US government
June 24, 2009Sales and Marketing Medicare, US, US healthcare, healthcare
Drug makers have agreed with the US government to spend $80 billion over the next ten years in a bid …
Helsinn restructures API units in Switzerland, Ireland
June 23, 2009Manufacturing and Production Helsinn
Pharmaceutical group Helsinn is planning to expand its manufacturing capabilities with a new round of investment at a production facility …
Working Life: Kevin Crowe
June 23, 2009Sales and Marketing Merck Serono, WL, sales force effectiveness
How did you find your way into your current role?I have worked for several years in the Canadian pharmaceutical industry …
Astellas signs European deal in pain management
June 23, 2009Research and Development, Sales and Marketing Astellas
Astellas has struck a deal with Californian company NeurogesX to market in Europe a treatment for pain linked to peripheral …
Pharma quotas ‘do not affect parallel trade’
June 23, 2009Manufacturing and Production EAEPC, parallel trade
The stable market for parallel imports in recent years suggests pharma quotas on wholesalers have not dampened the trade, according to a parallel distributor …
Pharmaceutical manufacturing: news in brief
June 22, 2009Manufacturing and Production Genzyme
Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Genzyme, Norwich Pharma and Kemwell/Boehringer Ingelheim, progress with …
Merck Serono breast cancer vaccine enters phase III
June 22, 2009Research and Development Cancer, Merck Serono, Stimuvax, vaccines
Merck Serono is to begin a global phase III study for its therapeutic cancer vaccine Stimuvax in patients with advanced, …
Swiss CRO moves into Indian clinical trials market
June 22, 2009Research and Development CRO, Switzerland
Switzerland-based contract research organisation PFC Pharma Focus has set up an Indian subsidiary with the help of Excel Life Sciences, …
NICE takes on quality and outcomes
June 19, 2009GP, NICE, healthcare, qof, quality
Some developments at NICE, now celebrating its 10th birthday, may have passed you by. They have moved beyond their technology …
NHS under fire for productivity failure
June 19, 2009NHS, healthcare
The NHS is under fire from MPs for failing to improve productivity despite a pay bill which has risen 5.2% …
BMS and AZ launch diabetes patient survey
June 19, 2009Medical Communications, Sales and Marketing diabetes
Bristol-Myers Squibb and AstraZeneca have joined forces with Diabetes UK to launch a national patient survey on the effects of …
Sanofi to donate millions of flu vaccines for developing world
June 18, 2009Research and Development Sanofi-Aventis, h1n1, vaccines
Sanofi-Aventis is to set aside 100 million flu vaccine doses for the developing world in order to fight the emerging …
Boehringer collaboration targets Alzheimer’s
June 18, 2009Research and Development, Sales and Marketing Boehringer, CNS
Boehringer Ingelheim and Pennsylvania-based Vitae Pharmaceuticals have signed a global agreement to develop novel treatments for Alzheimer's. The disease currently …
ASCO 2009: advance of the blockbusters
June 18, 2009Sales and Marketing ASCO, Cancer
Key highlights of the recent American Society of Clinical Oncology's 45th Annual Meeting in Florida saw current blockbusters advance standard …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
